Systemic Hyalinosis With Heterozygous CMG2 Mutations: A Case Report and Review of Literature
Related Experiment Video
Updated: Mar 25, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Maral Rahvar1, Joyce Teng, Jinah Kim
1*Department of Pathology, Loma Linda University, Loma Linda, CA; and Departments of †Dermatology, and ‡Pathology, Stanford University, Stanford, CA.
Abstract:
Juvenile hyaline fibromatosis (JHF) is a rare autosomal recessive disorder characterized by hyalinizing fibrosis of the skin and internal organs. Clinical features include multiple papular skin lesions, gingival hyperplasia, joint contractures, and osteolytic bone lesions. The systemic variant of JHF, known as infantile systemic hyalinosis (ISH), has an early onset and poor prognosis. Histological examination of cutaneous lesions shows bland-appearing fibroblasts within amorphous eosinophilic hyaline depositions. JHF and infantile systemic hyalinosis form a clinical spectrum with higher mortality that is typically observed in systemic cases. Here, the authors present a case of systemic hyalinosis with a heterozygous mutation in CMG2 that resulted in improved survival.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cytomegalovirus Disease
Cardiomyopathy II: Dilated Cardiomyopathy

